# Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy

> **NCT00991224** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 2 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** WT-gag-TCR modified T cells
- **BIOLOGICAL:** α/6-gag-TCR modified T cells
- **OTHER:** STI or Drug Holiday

## Key facts

- **NCT ID:** NCT00991224
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2019-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00991224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00991224, "Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00991224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*